The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder.
Dijkstra FM, van de Loo AJ, Abdulahad S, Bosma ER, Hartog M, Huls H, Kuijper DC, de Vries E, Solanki B, Singh J, Aluisio L, Zannikos P, Stuurman FE, Jacobs GE, Verster JC.
Dijkstra FM, et al. Among authors: van de loo aj.
J Psychopharmacol. 2022 May;36(5):614-625. doi: 10.1177/02698811221078764. Epub 2022 Feb 25.
J Psychopharmacol. 2022.
PMID: 35212235
Free PMC article.
Clinical Trial.